Both in Pharmaceuticals
Sarepta Therapeutics, vs Nuvation Bio
Over the past year SRPT returned −1.0% and NUVB returned +74.5%; their daily moves had a correlation of 0.25.
SRPT −1.0% NUVB +74.5%Growth of $1, one year, split-adjusted
| Metric | SRPT | NUVB |
|---|---|---|
| Price | $18.64 | $5.62 |
| Market cap | $1.97B | $1.97B |
| Today | −0.85% | +0.36% |
| 1 month | −10.6% | −15.6% |
| 6 months | −9.0% | +38.8% |
| Year to date | −13.4% | −37.3% |
| 1 year | +1.5% | +75.6% |
| Revenue growth (YoY) | −34.3% | +555.6% |
| Gross margin | 62.8% | 73.0% |
| Net margin | −1.2% | −198.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 11.6× |
| Net cash | -$59.1M | $399.4M |
| Dividend yield | — | — |
| Volatility (60d) | 62.5% | 54.8% |
| Short % of float | 25.9% | 22.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).